BOSTON and VANCOUVER, BC, Nov. 10, 2025 /PRNewswire/ -- Alpha-9 Oncology ("Alpha-9" or "the Company"), a clinical-stage radiopharmaceutical company developing targeted cancer therapies, today ...
Phase 1 study advances A9-3408, an Actinium-225-based radiotherapeutic, building on the progress of the company's imaging agent, A9-3202, which entered the clinic last year Robert Meehan, M.D., ...
Sony’s v4.0 firmware for the Sony a1 II & Sony a9 III adds real-time Recognition AF+, new Creative Looks, and key workflow enhancements. Sony says new v4.0 firmware for the Sony Alpha 1 II (a1 II) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results